Oseltamivir News and Research

RSS

Host-targeting drugs offer new way to fight flu resistance

A drug that targets the host rather than the virus could get around the problem of anti-viral resistance. Every year, hundreds of thousands of people die of seasonal influenza, caused by infection with influenza A and B viruses.

1 Sep 2026

Antiviral treatment lowers ICU risk for children with influenza

A new nationwide study finds antiviral treatment is linked to fewer intensive care unit (ICU) admissions and shorter hospital stays for children hospitalized with influenza.

10 Aug 2026

Flu drugs may reduce cognitive decline in people with HIV

A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and extended into preclinical drug trials.

5 Jun 2026

Rapid antiviral treatment reduces nursing home hospitalizations during flu outbreaks

In nursing homes, influenza spreads quickly. Even in facilities with separate wings, staff move throughout the home, caring for medically complex older adults who often share rooms.

31 Mar 2026

Baloxavir reduces flu-related hospitalizations more than oseltamivir

A study reveals baloxavir outperforms oseltamivir in reducing hospitalization rates for influenza, highlighting its clinical advantages in outpatient settings.

17 Dec 2025

Virus shells use asymmetry to control RNA release and infection

Viruses are typically described as tiny, perfectly geometric shells that pack genetic material with mathematical precision, but new research led by scientists at Penn State reveals a deliberate imbalance in their shape that helps them infect their hosts.

12 Dec 2025

Flu virus triggers neuropsychiatric symptoms not the medication

For decades, medical professionals debated whether a common antiviral medication used to treat flu in children caused neuropsychiatric events or if the infection itself was the culprit.

4 Aug 2025

New drug combo outperforms Tamiflu in fighting deadliest flu strains

A surprising new drug combo—including a compound found in chocolate—has outperformed Tamiflu in fighting the flu, according to a study published in PNAS.

4 Aug 2025

ADC189 shows promise as a single-dose treatment for influenza

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and mortality.

24 Jun 2025

What makes H5N1 a pandemic risk and how can we stop it?

A new PEARLS article in PLoS Pathogens reviews the rapid evolution and pandemic potential of emerging influenza A viruses, with a focus on H5N1. It highlights scientific advances and future strategies to outpace the virus, from next-generation vaccines to AI-driven antiviral discovery.

19 May 2025

Current antivirals not successful in treating severe H5N1 bird flu infections

As the H5N1 avian influenza outbreak continues, scientists are working to better understand the virus's threat to human health.

17 Mar 2025

In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domain

Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, resulting in the coronavirus disease 2019 (COVID-19) pandemic.

4 Feb 2025

Mild avian flu cases in US spark safety warnings for poultry and dairy sectors

Researchers identify 46 mild cases of avian influenza A(H5N1) in U.S. poultry and dairy workers, highlighting low PPE adherence and potential outbreak risks.

2 Jan 2025

Scientists detect rare H5N1 avian flu strain in Australian child after travel to India

A 2.5-year-old returning to Australia from India was infected with a reassortant H5N1 virus, revealing genetic mixing between avian influenza clades and gaps in South Asian surveillance.

18 Dec 2024

Research identifies respiratory transmission potential of H5N1 virus

A highly pathogenic avian influenza (HPAI) H5N1 virus, isolated from the eye of a farm worker who became infected through contact with dairy cows, was lethal in mice and ferrets infected in a high-containment laboratory environment, according to a new study in Nature.

28 Oct 2024

US study uncovers antiviral resistance in swine-origin influenza, urging enhanced pandemic surveillance

Researchers in the US analyzed swine-origin influenza viruses, identifying key mutations that could reduce antiviral drug effectiveness and threaten pandemic preparedness.

9 Oct 2024

Low-cost CRISPR-based paper strip test offers rapid influenza diagnosis

Fewer than one percent of people who get the flu every year get tested, in part because most tests require trained personnel and expensive equipment.

21 Jun 2024

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

A study in the Emerging Infectious Diseases journal shows treating 20% of COVID-19 patients with Paxlovid could save up to 0.85 million lives and reduce the economic burden by US $170.17 billion in the US.

14 Jan 2024

Study highlights variable use and rising costs of antivirals in treating pediatric influenza in the U.S.

The Pediatrics study analyzes trends in antiviral usage among U.S. children and adolescents with influenza, revealing significant variations in dispensing rates and costs, and low usage among children under six years, emphasizing the need for improved treatment strategies.

16 Nov 2023

Study reveals underuse of antiviral medications in young children with influenza

Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a new study reports an underuse of the treatment.

13 Nov 2023